NCT02978157View on ClinicalTrials.gov

Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

esomeprazole+amox+levo

esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., levofloxacin 500 mg o.d.

DRUG

esomeprazole+bismuth+tetra+levo

esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s., and levofloxacin 500 mg o.d.

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02978157 - Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection | Biotech Hunter | Biotech Hunter